Point72 Middle East Fze Bristol Myers Squibb CO Put Options Transaction History

Point72 Middle East Fze

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2023 Feb 14, 2024	SELL	$48.48 - $57.85 $2.49 Million - $2.97 Million	-51,300 Reduced 50.74%	49,800 $2.56 Million
Q3 2023 Nov 14, 2023	BUY	$57.89 - $64.73 $3.42 Million - $3.83 Million	59,100 Added 140.71%	101,100 $5.87 Million
Q2 2023 Aug 14, 2023	BUY	$63.71 - $70.74 $1.94 Million - $2.16 Million	30,500 Added 265.22%	42,000 $2.69 Million
Q1 2023 May 15, 2023	SELL	$65.71 - $74.53 $2.72 Million - $3.09 Million	-41,400 Reduced 78.26%	11,500 $797,000
Q4 2022 Feb 14, 2023	BUY	$68.48 - $81.09 $3.62 Million - $4.29 Million	52,900 New	52,900 $0

2,533

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $124B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Point72 Middle East Fze, based on Form 13F filings with the SEC.

Stay updated on Point72 Middle East Fze with notifications on news.